TGFβ RII activators are a diverse class of chemical compounds that influence the activity of Transforming Growth Factor Beta Receptor II (TGFβ RII) indirectly. TGFβ RII is a crucial receptor in the TGFβ signaling pathway, which plays a fundamental role in cellular processes such as proliferation, differentiation, and apoptosis. These activators modulate TGFβ RII by targeting various cellular components and pathways that interact with or regulate the receptor. It's important to note that the modulation of TGFβ RII is a complex and intricate process, as it often involves intricate feedback mechanisms and crosstalk with other signaling pathways. One of the key activators is LY2109761, which inhibits the kinase activity of TGFβ RII. By doing so, it relieves the negative feedback loop that would typically downregulate the receptor's activity. Similarly, SB431542 acts as an inhibitor for kinases associated with TGFβ RII, which can lead to a compensatory increase in receptor activation. The compound GW788388 also inhibits TGFβ RII kinase activity, enhancing the receptor's signaling output.
Another group of activators interferes with pathways that have crosstalk with the TGFβ signaling pathway. For instance, SP600125 inhibits JNK (c-Jun N-terminal kinase), which is known to cross-talk with TGFβ signaling. This inhibition can indirectly promote TGFβ RII activation by preventing JNK-mediated suppression. U0126 is a MEK (Mitogen-Activated Protein Kinase Kinase) inhibitor that impacts TGFβ RII indirectly by inhibiting upstream regulators, enhancing the receptor's activity. In summary, TGFβ RII activators are a diverse group of chemical compounds that indirectly modulate the activity of the TGFβ RII receptor by targeting various pathways and cellular components. These activators can enhance receptor activation by inhibiting factors that would otherwise suppress its activity or by interfering with pathways that have crosstalk with the TGFβ signaling pathway. Their complex mechanisms make them important tools for researchers studying TGFβ RII signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Acts as an inhibitor for TGFβ RII-associated kinases, leading to compensatory receptor activation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits tyrosine phosphatases, stabilizing the active phosphorylated state of TGFβ RII. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may activate TGFβ RII indirectly via crosstalk between the MAPK and TGFβ pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, thereby disrupting a pathway that opposes TGFβ RII signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor; affects cellular contractility and can indirectly upregulate TGFβ RII signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases; enhances TGFβ RII signaling by removing an inhibitory factor. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor; epigenetic changes can lead to elevated levels of TGFβ RII. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
ERK inhibitor; alleviating ERK-mediated inhibition can lead to TGFβ RII activation. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
EGFR inhibitor; EGFR suppression can enhance TGFβ RII signaling through crosstalk mechanisms. | ||||||